- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Intestinal bypass.
Displaying page 1 of 1.
EudraCT Number: 2014-002970-36 | Sponsor Protocol Number: 54508 | Start Date*: 2016-06-06 |
Sponsor Name:Maastricht University Medical Center | ||
Full Title: Human intestinal ischemia and reperfusion | ||
Medical condition: The participants enrolled in this study will all undergo major upper abdominal surgery (i.e. mostly Pylorus Preserving Pancreatico Duodenectomy or whipple procedure) mostly for pancreatic cancer, p... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000397-19 | Sponsor Protocol Number: Ctrl-DM2 | Start Date*: 2014-09-09 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Effects of Combined Treatment of Surgery and Liraglutide on Glycemic Variability and Control in type 2 Diabetes Mellitus: The Ctrl-DM2 Study | ||
Medical condition: type 2 diabetes with morbid obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000548-71 | Sponsor Protocol Number: NOK0020 | Start Date*: 2021-01-25 |
Sponsor Name:Nederlandse Obesitas Kliniek | ||
Full Title: Liraglutide for low-responders after bariatric surgery | ||
Medical condition: Morbid obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-010191-19 | Sponsor Protocol Number: ALS-002-2009 | Start Date*: 2010-03-19 | |||||||||||
Sponsor Name:Alloksys Life Sciences BV | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled phase IIIa study on bIAP, an anti-inflammatory moiety, in patients undergoing combined aortic valve replacement and coronary artery bypass grafting. | |||||||||||||
Medical condition: Patients undergoing invasive cardiac surgery with prolonged perfusion time. This often is associated with potentially life-threatening inflammatory complications due to ischemic periods during surg... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002126-90 | Sponsor Protocol Number: 2019/399/HP | Start Date*: 2021-03-09 | ||||||||||||||||
Sponsor Name:Direction de la Recherche Clinique et de l’Innovation – CHU de Rouen | ||||||||||||||||||
Full Title: Opioid-Free Anesthesia in Cardiac Surgery | ||||||||||||||||||
Medical condition: Patients undergoing cardiac surgery under extracorporeal circulation with at least one aorto-coronary bypass and the removal of at least one internal mammary artery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002663-33 | Sponsor Protocol Number: NUH-ALS-2015-04 | Start Date*: 2018-11-05 | |||||||||||
Sponsor Name:Alloksys Life Sciences BV | |||||||||||||
Full Title: Preventing Oxidative stress induced Ischemic Injury and Systemic Inflammation complications during and after invasive Cardiac surgery with Alkaline Phosphatase (APPIRED III) | |||||||||||||
Medical condition: systemic inflammation as side-effect of heart-lung machine during cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) NL (Completed) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002076-41 | Sponsor Protocol Number: 0667 | Start Date*: 2018-08-23 | ||||||||||||||||
Sponsor Name:University of Leicester | ||||||||||||||||||
Full Title: A RANDOMISED CONTROLLED TRIAL OF PRE-SURGERY SODIUM VALPROATE, FOR THE PREVENTION OF ORGAN INJURY IN CARDIAC SURGERY: Val-CARD | ||||||||||||||||||
Medical condition: Reduction of myocardial and kidney injury risk of post cardiac surgery by increasing the expression of genes that promote myocardial mitochondrial homeostasis via effects on chromatin histone deace... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
